NCT03687242Phase 2Completed

Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia

Study sponsor: Spruce Biosciences

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2019-07-08Actual
Enrollment · participants11Actual
Source updated2025-04-01Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview